i don t want to be muted because the people need to speak. for those of you who are just joining you, this is the march 17th, 2020 commission meeting and we re doing this for the first time using microsoft. please excuse us if we have any technology issues. this process may be different than we normally do. if i may, i may move on to item 2, the approval of the march 3rd, 2020 minutes. do we need to do a call to order and role call? yes, thank you. so i ll start with you, commissioner. (role call). we ll move on to item 2, the approval of the march 2 minutes. reviewing the minutes of the previous meeting, does anybody have a motion to approve? so moved. second. all those i in favor? do we need to do a role call? (role call). thank you. item 3, the director s report. the director s report is in front of you and i would ask that if you have any questions, of course, i m happy to answer them, but given that the majority of our meeting with focus on covid-19, i
issue for us. it s a key issue, as you know, across the country right now within our public health lab under the direction of dr. susan philip and they ve done an amazing job of implementing testing. our capacity is relatively small and they re having to prioritize testing the people who are most in need of testing, requirementy symptoms in the hospital, at high risk for first-degree exposures and then healthcare workers. so we re really focusing on those flee populations 03 thre. to give you an idea of how our day-to-day is going right now, we re injecting a capacity of a day s worth of test or at the best, a week s worth. and so we re getting tests delivered to us by the cdc in the very challenging fashion because we re simply not able to be assure ed this either w assuh tests to last for months or to expand our capacity to run 24 hours a day. so that s within the dph side. within our public health lab side. we re also working with private labs including quest diagnostics
this process may be different than we normally do. if i may, i may move on to item 2, the approval of the march 3rd, 2020 minutes. do we need to do a call to order and role call? yes, thank you. so i ll start with you, commissioner. (role call). we ll move on to item 2, the approval of the march 2 minutes. reviewing the minutes of the previous meeting, does anybody have a motion to approve? so moved. second. all those i in favor? do we need to do a role call? (role call). thank you. item 3, the director s report. the director s report is in front of you and i would ask that if you have any questions, of course, i m happy to answer them, but given that the majority of our meeting with focus on covid-19, i will not need what s in front of you, but i m happy to answer any questions you see fit to raise at the time. any commissioner questions? i m not receivining a public comment request. commissioners, if not, we can move on to the next item. item 4, the
technology issues. this process may be different than we normally do. if i may, i may move on to item 2, the approval of the march 3rd, 2020 minutes. do we need to do a call to order and role call? yes, thank you. so i ll start with you, commissioner. (role call). we ll move on to item 2, the approval of the march 2 minutes. reviewing the minutes of the previous meeting, does anybody have a motion to approve? so moved. second. all those i in favor? do we need to do a role call? (role call). thank you. item 3, the director s report. the director s report is in front of you and i would ask that if you have any questions, of course, i m happy to answer them, but given that the majority of our meeting with focus on covid-19, i will not need what s in front of you, but i m happy to answer any questions you see fit to raise at the time. any commissioner questions? i m not receivining a public comment request. commissioners, if not, we can move on to the next i
today is that we all have plans for capacity, but we aren t yet filling it. so that s the question we are at now. tthe other thing i can tell you that s exciting, we re looking to see beyond the capacity, in our individual hospitals, what capacity we utilize in hospitals that have vacant beds that aren t staffed. and we ve identified a unit, a full med surge unit and an old critical care unit at st. francis to use for that purpose. the capacity of the med surge unit is about 40 and the critical care unit is eight. and so we looked at that unit last night and now we re in the process of seeing what it would cost to staff it. in general, we re looking at a model whereby the basic support services are covered by st. francis and we re looking at registries, essentially, to fill the nursing positions and then a shared model of provider services between dignity ucsf and ucsfg. i m happy to answer any other questions. there s a lot of detail i haven t covered by i m happy to answer